EUVIMEDEUVIMED entdecken
Crossref

A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses

Fengjun Xiang, Yi Xu, Changyun Liu, Xiaolong Li, Rang Wang, Haodong Zhang, Shanshan Dong, Jiamo Huang, Tingting Luo, Yifeng Qin, Kang Ouyang, Yeshi Yin und 3 weitere

Microbial Pathogenesis · 2026-09 · 218 · 108638

DOI: 10.1016/j.micpath.2026.108638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026-09. Verfasst von Fengjun Xiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Infectious Diseases and Molecular Immunology, College of Animal Science and Technology, Guangxi University, Nanning, 530004, PR …. Hauptthemen laut MEDLINE: Influenza Vaccines, Orthomyxoviridae Infections, Viral Nonstructural Proteins, Swine Diseases. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Guangxi Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Swine influenza A viruses (swIAVs) undergo frequent reassortment and evolution, posing significant threats to both animal and human health. In this study, we employed reverse genetics to generate five recombinant viruses and evaluated their potential as vaccine candidates. Through pathogenicity evaluation in mice, we identified two promising candidates: an inactivated vaccine (rPR8-JGL16+2) and a live-attenuated vaccine (rPR8-JGL15+3). Both vaccines induced robust hemagglutination inhibition (HI) antibody responses and specific IgG levels against homologous strains. Notably, the attenuated rPR8-JGL15+3 vaccine provided complete protection against both homologous (H1N1) and heterologous (H3N2) viral challenges, with no detectable viral loads in the lungs or nasal turbinate. Although the inactivated rPR8-JGL16+2 vaccine exhibited effective protective efficacy against influenza viruses, it did not fully inhibit the replication of heterologous viruses in mice. Histopathological assessment revealed that rPR8-JGL15+3 immunization prevented significant lung damage, contrasting with the mild pathology observed in rPR8-JGL16+2-vaccinated animals. These findings demonstrate the successful development of novel vaccine candidates against avian-like H1N1 swIAV, with the attenuated vaccine showing promise for broad protection against circulating strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesOrthomyxoviridae InfectionsViral Nonstructural ProteinsSwine DiseasesCross ProtectionAnimalsVaccines, AttenuatedReverse GeneticsAntibodies, ViralMiceLungSwineInfluenza A Virus, H1N1 SubtypeMice, Inbred BALB CInfluenza A Virus, H3N2 SubtypeFemaleHemagglutination Inhibition TestsImmunoglobulin GViral LoadVaccines, Inactivated

Stichwörter der Autor:innen

Cross-protectionInactivated vaccineLive-attenuated vaccineReverse geneticsSwine influenza virus

Substanzen

Influenza VaccinesVaccines, AttenuatedAntibodies, ViralViral Nonstructural ProteinsINS1 protein, influenza virusImmunoglobulin GVaccines, Inactivated

Autor:innen und Institutionen

  • Laboratory of Animal Infectious Diseases and Molecular Immunology, College of Animal Science and Technology, Guangxi University, Nanning, 530004, PR China.
  • Guangxi Nongken Yongxin Animal Husbandry Group Jinguang Co., Ltd., Nanning, 530042, PR China.
  • Laboratory of Animal Infectious Diseases and Molecular Immunology, College of Animal Science and Technology, Guangxi University, Nanning, 530004, PR China; Guangxi Zhuang Autonomous Region Engineering Research Center of…

Förderung

  • Guangxi Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Xiang, F., Xu, Y., Liu, C., Li, X., Wang, R., Zhang, H., Dong, S., Huang, J., Luo, T., Qin, Y., Ouyang, K., Yin, Y., Wei, Z., Huang, W., & Chen, Y. (2026). A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses. Microbial Pathogenesis, 218, 108638. https://doi.org/10.1016/j.micpath.2026.108638

Vancouver

Xiang F, Xu Y, Liu C, Li X, Wang R, Zhang H, et al. A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses. Microbial Pathogenesis. 2026;218:108638. doi:10.1016/j.micpath.2026.108638

BibTeX
@article{Xiang2026,
  author = {Xiang, Fengjun and Xu, Yi and Liu, Changyun and Li, Xiaolong and Wang, Rang and Zhang, Haodong and Dong, Shanshan and Huang, Jiamo and Luo, Tingting and Qin, Yifeng and Ouyang, Kang and Yin, Yeshi and Wei, Zuzhang and Huang, Weijian and Chen, Ying},
  title = {A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses},
  journal = {Microbial Pathogenesis},
  year = {2026},
  volume = {218},
  pages = {108638},
  doi = {10.1016/j.micpath.2026.108638}
}
Kostenlos starten →